In an exclusive interview conducted by Oncology Frontier at the European Society for Medical Oncology (ESMO) symposium, we had the privilege to engage with the distinguished Professor Kjetil Boye. Renowned for his expertise in oncology, Professor Boye shared his insights and reflections on his recent participation in a special symposium and a mini oral session. This esteemed oncologist’s experiences shed light on the evolving landscape of cancer research and treatment. Among the various topics covered, Professor Boye provides a glimpse into the new drugs that left a lasting impression during the symposium. Let’s delve into the highlights of this insightful conversation with a prominent figure in the field of oncology.
